— News, features, and commentary about cancer-related issues.

July 17, 2026

• 2 min read

The Medicare physician fee schedule proposed by CMS for 2027 will result in a 1.5% payment cut for hematology/oncology and a 1.5% increase for radiation oncology, the American Society of Clinical Oncology estimated.

The FDA approved the first generics of the EGFR inhibitor afatinib (Gilotrif) for non-small cell lung cancer.